APA (7th ed.) Citation

Behrens, R. H., Cramer, J. P., Jelinek, T., Shaw, H., von Sonnenburg, F., Wilbraham, D., . . . DuPont, H. L. (2014). Efficacy and safety of a patch vaccine containing heat-labile toxin from Escherichia coli against travellers' diarrhoea: A phase 3, randomised, double-blind, placebo-controlled field trial in travellers from Europe to Mexico and Guatemala. The Lancet infectious diseases, 14(3), 197-204. https://doi.org/10.1016/S1473-3099(13)70297-4

Chicago Style (17th ed.) Citation

Behrens, Ronald H., et al. "Efficacy and Safety of a Patch Vaccine Containing Heat-labile Toxin from Escherichia Coli Against Travellers' Diarrhoea: A Phase 3, Randomised, Double-blind, Placebo-controlled Field Trial in Travellers from Europe to Mexico and Guatemala." The Lancet Infectious Diseases 14, no. 3 (2014): 197-204. https://doi.org/10.1016/S1473-3099(13)70297-4.

MLA (9th ed.) Citation

Behrens, Ronald H., et al. "Efficacy and Safety of a Patch Vaccine Containing Heat-labile Toxin from Escherichia Coli Against Travellers' Diarrhoea: A Phase 3, Randomised, Double-blind, Placebo-controlled Field Trial in Travellers from Europe to Mexico and Guatemala." The Lancet Infectious Diseases, vol. 14, no. 3, 2014, pp. 197-204, https://doi.org/10.1016/S1473-3099(13)70297-4.